ZIM Laboratories Limited (BOM:541400)
64.09
+0.47 (0.74%)
At close: Mar 27, 2026
ZIM Laboratories Market Cap
ZIM Laboratories has a market cap or net worth of 3.4 billion as of March 27, 2026. Its market cap has decreased by -19.94% in one year.
Market Cap
3.40B
Enterprise Value
4.59B
Revenue
3.78B
Ranking
n/a
PE Ratio
44.35
Stock Price
64.09
Market Cap Chart
Since June 11, 2018, ZIM Laboratories's market cap has increased from 1.68B to 3.40B, an increase of 102.40%. That is a compound annual growth rate of 9.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 3.43B | -2.13% |
| Dec 31, 2025 | 3.50B | -33.11% |
| Dec 31, 2024 | 5.24B | -6.72% |
| Dec 29, 2023 | 5.62B | 18.57% |
| Dec 30, 2022 | 4.74B | 146.60% |
| Dec 31, 2021 | 1.92B | 31.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kilitch Drugs (India) | 5.34B |
| Jenburkt Pharmaceuticals | 4.45B |
| Albert David | 3.71B |
| Amanta Healthcare | 3.39B |
| Medicamen Biotech | 3.18B |
| Medico Remedies | 2.99B |
| Trident Lifeline | 2.93B |
| Sat Kartar Life | 2.55B |